[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 7, 2006

High-Dose Statins and the IDEAL Study

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295(21):2476-2479. doi:10.1001/jama.295.21.2477-a

To the Editor: The IDEAL study1 is 1 of 4 recent large clinical trials that have examined whether high-dose statins improve outcomes compared with conventional doses. The first 2 trials (PROVE-IT2 and A to Z3) enrolled patients with acute coronary syndromes (ACS), whereas the latter 2 trials (TNT4 and IDEAL1) enrolled patients with stable coronary artery disease. The results from these trials appear to conflict: PROVE-IT and TNT found statistically significant differences, whereas A-to-Z and IDEAL did not. Some of these conflicts may be related to the study designs.

First Page Preview View Large
First page PDF preview
First page PDF preview
×